Patent US5486593A successfully refreshed from Google Patents.
US5486593A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Medical devices fabricated from copolymers having recurring carbonate units
Assignee: United States Surgical Corp
•
Filing: 1994-09-23
•
Granted: 1996-01-23
•
Expires: 2014-09-23
Abstract
Abstract This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.
Inventors
- 👤 Regianld T. Tang
- 👤 Frank Mares
- 👤 William J. Boyle, Jr.
- 👤 Tin-Ho Chiu
- 👤 Kundanbhai M. Patel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 19:02
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/18; A61L15/00; A61L15/16; A61L15/42; A61L15/64; A61L17/00; A61L17/06; A61L17/10; A61L31/00; A61L31/04; A61L31/06; Y; Y10; Y10T; Y10T442/00; Y10T442/20; Y10T442/2508; Y10T442/2525; Y10T442/30; Y10T442/3976; Y10T442/60; Y10T442/696
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
216 words
A medical device formed totally or in part of one or more biopolymers selected from the group consisting of copolymers containing repeating units derived from a dioxanone and at least one recurring monomeric unit of the following General Structures I and II: ##STR12## wherein: Z is --C(R 5 R 6 )], --NR 5 ], --O-- or a combination thereof, where Z is selected such that there are no adjacent heteroatoms; n is from 1 to about 8; m is from 1 to about 8; R 1 , R 2 , R 3 , and R 4 are the same or different at each occurrence and are hydrogen, aryloxyalkyl, alkoxyaryl, aryloxyaryl, arylalkyl, alkylarylalkyl, arylalkylaryl, alkylaryl, arylcarbonylalkyl, alkyl, aryl, alkylcarbonylalkyl, cycloalkyl, arylcarbonylaryl, alkylcarbonylaryl, alkoxyalkyl, or aryl or alkyl substituted with one or more biologically compatible substituents; and R 5 and R 6 are the same or different and are R 1 , R 2 , R 3 , R 4 , dialkylamino, diarylamino, alkylarylamino, alkoxy, aryloxy, alkanoyl, or arylcarbonyl, or any two of R 1 to R 6 together may form an alkylene chain completing a 3, 4, 5, 6, 7, 8 or 9 membered alicyclic fused, spiro, bicyclic and/or tricyclic ring system, which system may optionally include one or more non-adjacent carbonyl, oxa, alkylaza or acylaza groups.
Claim 2
Dependent Claim
216 words
A medical device formed totally or in part of one or more biopolymers selected from the group consisting of copolymers containing repeating units derived from a dioxanone and at least one recurring monomeric unit of the following General Structures I and II: ##STR12## wherein: Z is --C(R 5 R 6 )], --NR 5 ], --O-- or a combination thereof, where Z is selected such that there are no adjacent heteroatoms; n is from 1 to about 8; m is from 1 to about 8; R 1 , R 2 , R 3 , and R 4 are the same or different at each occurrence and are hydrogen, aryloxyalkyl, alkoxyaryl, aryloxyaryl, arylalkyl, alkylarylalkyl, arylalkylaryl, alkylaryl, arylcarbonylalkyl, alkyl, aryl, alkylcarbonylalkyl, cycloalkyl, arylcarbonylaryl, alkylcarbonylaryl, alkoxyalkyl, or aryl or alkyl substituted with one or more biologically compatible substituents; and R 5 and R 6 are the same or different and are R 1 , R 2 , R 3 , R 4 , dialkylamino, diarylamino, alkylarylamino, alkoxy, aryloxy, alkanoyl, or arylcarbonyl, or any two of R 1 to R 6 together may form an alkylene chain completing a 3, 4, 5, 6, 7, 8 or 9 membered alicyclic fused, spiro, bicyclic and/or tricyclic ring system, which system may optionally include one or more non-adjacent carbonyl, oxa, alkylaza or acylaza groups.
Claim 3
Dependent Claim
62 words
The device of claim 1, wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different and are selected from the group consisting of hydrogen alkyl, cycloalkyl, alkylaryl, alkoxyalkyl, aryloxyalkyl, aryloxyaryl, aryl and arylalkyl groups, and aryl, arylalkyl or alkylaryl substituted with one or more alkyl, alkoxy and alkoxyalkyl groups.
Claim 4
Dependent Claim
57 words
The device of claim 2, wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different and are selected from the groups consisting of hydrogen alkyl, cycloalkyl, alkylphenyl, alkoxyalkyl and phenylalkyl, and phenyl, alkylphenyl and phenylalkyl substituted with one or more alkyl or alkoxy groups.
Claim 5
Dependent Claim
131 words
The device of claim 1, wherein the bipolymers comprises at least one type of recurring monomeric unit moieties selected from the group consisting of: ##STR13## wherein: R 5 and R 6 are the same or different and are hydrogen, alky, aryl, cycloalkyl, arylalkyl, alkoxyalkyl or aryloxyalkyl, or aryl or arylalkyl substituted with one or more alkyl or alkoxy groups alkoxy, alkanoyl, dialkylamino, or R 5 and R 6 together may form an alkylene chain completing a 4, 5, 6, 7, 8, 9, or 10 membered spiro, bicyclic and/or tricyclic ring structure which structure may optionally include one or more non-adjacent divalent carbonyl, oxa, alkylaza or arylaza groups, with the proviso that at least one of R 5 or R 6 is other than hydrogen; and n is 1, 2 or 3.
Claim 6
Dependent Claim
14 words
The device of claim 4, wherein R 5 and R 6 are the same.
Claim 7
Dependent Claim
13 words
The device of claim 4, wherein R 5 and R 6 are hydrogen.
Claim 8
Dependent Claim
20 words
The device of claim 4, wherein R 5 and R 6 are alkyl of about 1 to 4 carbon atoms.
Claim 9
Dependent Claim
10 words
The device of claim 4, wherein the dioxanone is p-dioxanone.
Claim 10
Dependent Claim
12 words
The device of claim 1, wherein said copolymer is a block copolymer.
Claim 11
Dependent Claim
42 words
The device of claim 1, wherein the wt % of recurring monomeric units of the Structure I or Structure II included in said copolymer is at least about 50 wt % based on the total wt of monomeric units in the copolymer.
Claim 12
Dependent Claim
12 words
The device of claim 1, wherein said copolymer is a random copolymer.
Claim 13
Dependent Claim
27 words
The device of claim 1, which is totally or partially bioresorbable medical device suitable for implantation inside of a living system to promote regeneration of body tissue.
Claim 14
Dependent Claim
16 words
The device of claim 1, which is an orthopedic device for bone repair or fracture fixation.
Claim 15
Dependent Claim
14 words
The device of claim 1, which is a wound covering or wound closure device.
Claim 16
Dependent Claim
11 words
The device of claim 1, which further comprises a biodurable portion.
Claim 17
Dependent Claim
58 words
A bioabsorbable copolymer comprising monomeric units derived from a dioxanone and one or more monomeric units of formula: ##STR14## wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different at each occurrence and are hydrogen or alkyl and n is from 1 to about 8.
Claim 18
Dependent Claim
58 words
A bioabsorbable copolymer comprising monomeric units derived from a dioxanone and one or more monomeric units of formula: ##STR14## wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different at each occurrence and are hydrogen or alkyl and n is from 1 to about 8.
Claim 19
Dependent Claim
11 words
A copolymer as in claim 16, wherein the dioxanone is p-dioxanone.
Claim 20
Dependent Claim
22 words
A copolymer as in claim 16, wherein the copolymer contains a member from the group consisting of trimethylene carbonate and dimethyltrimethylene carbonate.
Claim 21
Dependent Claim
11 words
A copolymer as in claim 17, which is a random polymer.
Claim 22
Dependent Claim
11 words
A copolymer as in claim 17, which is a block copolymer.
Claim 23
Dependent Claim
11 words
A copolymer as in claim 18, wherein the dioxanone is p-dioxanone.
References Cited (Backward Citations)
US3248414A
Cited
US3301824A
Cited
US3301825A
Cited
FR1426964A
Cited
US3305605A
Cited
US3324070A
Cited
US3379693A
Cited
US3639503A
Cited
US3758443A
Cited
GB1272733A
Cited
US4079033A
Cited
US3952016A
Cited
US3959185A
Cited
US4052988A
Cited
US4079038A
Cited
US4160853A
Cited
US4070375A
Cited
DE2821570A1
Cited
GB1604178A
Cited
FR2391734A1
Cited
GB1604177A
Cited
US4300565A
Cited
US4157437A
Cited
US4243775A
Cited
US4190720A
Cited
US4423205A
Cited
US4429080A
Cited
US4562022A
Cited
EP0202444A2
Cited
US4754017A
Cited
US4705820A
Cited
US4791929A
Cited
US4920203A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-01-22 | 1999-07-24 | 2000-01-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-01-22 | 2003-07-24 | 2004-01-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-01-22 | 2007-07-24 | 2008-01-23 | $7700.00 | Window Closed / Lapsed |